0613 Effects of Pitolisant on Nighttime Sleep [PDF]
Ulf Kallweit, Annika Triller
openaire +1 more source
The Role of Pharmacotherapy for Excessive Daytime Sleepiness in OSA: A Changing Landscape? [PDF]
Chapman JL +4 more
europepmc +1 more source
Pitolisant Improves Depressive Symptoms in CPAP-Treated Patients with Obstructive Sleep Apnea and Severe Residual Sleepiness: First 12-Month Clinical Experience. [PDF]
Caratozzolo D +7 more
europepmc +1 more source
A proof-of-concept study of pitolisant for excessive daytime sleepiness in patients with Prader-Willi syndrome. [PDF]
Revana A +11 more
europepmc +1 more source
Advances in Non-CPAP Management of Obstructive Sleep Apnea: Spotlight on Pharmacological Therapies. [PDF]
Siciliano M +5 more
europepmc +1 more source
Clinical pearls for the treatment of narcolepsy. [PDF]
Bulloch MN, Geyer JD.
europepmc +1 more source
Narcolepsy as an immune-associated hypothalamic encephalopathy: orexin dysfunction and implications for precision sleep medicine. [PDF]
Arias-Carrión O +3 more
europepmc +1 more source
Sarcoidosis and Obstructive Sleep Apnoea: An Intriguing Relationship. [PDF]
Ciccarelli U +8 more
europepmc +1 more source
Simultaneous inhibition of cholinesterase and antagonism of histamine H3 receptors alleviates cognitive deficits and mitigates apoptosis in scopolamine-induced amnesia in mice. [PDF]
Ebdah W +6 more
europepmc +1 more source
Editorial: Non-invasive methods in drug metabolism and transport: insights from biological samples to oral administration. [PDF]
Wróblewski K, Zheng Y, Yue X.
europepmc +1 more source

